IGF1R and central nervous system cancer: Using genetic mouse models with NSCs or OPCs as the glioma cells‐of‐origin/mutation, it is shown that desirable outcomes of IGF1R knockout on cell growth require mutant cells with the development hierarchy to commit to the OPC identity.